Cytokinetics Inc (CYTK)

Fixed asset turnover

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue (ttm) US$ in thousands 7,530 7,815 9,952 95,246 91,781 141,206 139,967 56,649 58,061 9,383 45,819 46,569 47,834 47,611 14,609 16,776 20,245 23,344 29,275 29,730
Property, plant and equipment US$ in thousands 68,748 75,614 77,248 78,859 80,453 80,302 78,586 75,740 73,271 53,896 36,942 23,198 13,346 7,667 5,611 5,162 4,530 3,615 2,945 3,175
Fixed asset turnover 0.11 0.10 0.13 1.21 1.14 1.76 1.78 0.75 0.79 0.17 1.24 2.01 3.58 6.21 2.60 3.25 4.47 6.46 9.94 9.36

December 31, 2023 calculation

Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $7,530K ÷ $68,748K
= 0.11

The fixed asset turnover ratio measures how efficiently a company is utilizing its fixed assets to generate revenue. A higher ratio indicates that the company is generating more revenue per dollar of fixed assets.

Analyzing the fixed asset turnover of Cytokinetics Inc based on the provided data, we observe fluctuations in the ratio over the quarters. In Q1 2023, the fixed asset turnover was significantly higher at 1.24, indicating efficient utilization of fixed assets to generate revenue. This was followed by a noticeable decrease in Q2 2023 to 0.13, suggesting a decline in the efficiency of asset utilization.

The ratio improved in Q3 2023 to 0.10 but dropped again in Q4 2023 to 0.11. Comparing year-over-year performance, the fixed asset turnover has generally decreased from Q4 2022 to Q4 2023, indicating potentially less efficient utilization of fixed assets compared to the previous year.

Overall, the fluctuations in the fixed asset turnover ratio for Cytokinetics Inc suggest varying levels of efficiency in utilizing fixed assets to generate revenue over the quarters. Further analysis and investigation into the factors affecting these fluctuations may provide insights into the company's operational efficiency and future performance.


Peer comparison

Dec 31, 2023


See also:

Cytokinetics Inc Net Fixed Asset Turnover (Quarterly Data)